These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26873864)

  • 1. Chemotherapy in ovarian germ cell tumors: A systematic review.
    Simone CG; Markham MJ; Dizon DS
    Gynecol Oncol; 2016 Jun; 141(3):602-607. PubMed ID: 26873864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
    Lopes da Silva J; Luiz Renna N; Paulino E; de Melo AC
    Int J Gynecol Cancer; 2015 Jun; 25(5):786-91. PubMed ID: 25790041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Study to Determine the Dose Intensity of BEP Chemotherapy for Ovarian Malignant Germ Cell Tumors].
    Kusumoto S; Naito H; Imazu K; Kai I; Hamasaki A; Kazusa Y; Nakashima Y; Kodama M; Kumagai M; Ueda K
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):255-259. PubMed ID: 28292998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of ovarian germ cell tumors.
    Williams SD
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
    Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of recurrent and persistent malignant ovarian germ cell tumors: a narrative review.
    Nasioudis D; Pashankar FD
    Int J Gynecol Cancer; 2024 Sep; 34(9):1454-1460. PubMed ID: 38991656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of bilateral ovarian germ cell tumors.
    Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
    Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of male and female germ cell tumors.
    Williams SD; Loehrer PJ; Nichols CR; Einhorn LN
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):19-23; discussion 23-4. PubMed ID: 1384139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
    Weinberg LE; Lurain JR; Singh DK; Schink JC
    Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiles in non‑epithelial ovarian tumors.
    Chang RK; Li X; Mu N; Hrydziuszko O; Garcia-Majano B; Larsson C; Lui WO
    Int J Oncol; 2018 Jan; 52(1):55-66. PubMed ID: 29138809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy for ovarian malignant germ cell tumors].
    Nagai Y; Inamine M; Kudaka W; Aoki Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():648-55. PubMed ID: 23156326
    [No Abstract]   [Full Text] [Related]  

  • 17. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors.
    Abu Arja MH; Stanek JR; Finlay JL; AbdelBaki MS
    Childs Nerv Syst; 2018 Nov; 34(11):2179-2186. PubMed ID: 30076436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Ovarian Germ Cell Tumors in Postmenopausal Patients: The Royal Marsden Experience and Literature Review.
    Boussios S; Attygalle A; Hazell S; Moschetta M; McLachlan J; Okines A; Banerjee S
    Anticancer Res; 2015 Dec; 35(12):6713-22. PubMed ID: 26637887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.